Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05768841
Other study ID # VS1
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date March 15, 2023
Est. completion date September 30, 2024

Study information

Verified date November 2023
Source Ultra Sports Science Foundation
Contact Volker Scheer, Prof
Phone +33 4 25 36 79 54
Email contact@ultrasportsscience.org
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Participation in endurance sports has been increasing over the last few decades and our aim of our exploratory descriptive survey study is therefore to examine mental health issues in endurance athletes (marathon runners, ultra endurance runners, triathletes), employing the IOC assessment tool, to provide information on mental health issues in this population. Secondary objects are to evaluate risk factors for mental health issues in endurance athletes (like exercise behaviour, competition behaviour, age, gender, medical issues)


Description:

This study is an exploratory descriptive survey study. The study protocol will be largely replicated from the IOC consensus paper and the questionnaires based according to SMHAT 1 with an athlete-specific screening tool (APSQ) and further eleven subsequent disorder-specific screening tools: Eleven disorder specific screening tools: 1. General Anxiety Disorder-7 (GAD-7): assesses the presence of symptoms of anxiety. 2. Patient Health Questionnaire-9 (PHQ-9): assesses the presence of symptoms of depression. 3. Athlete Sleep Screening Questionnaire (ASSQ): assesses the presence of sleep disturbance. 4. Alcohol Use Disorders Identification Test Consumption (AUDIT-C): assesses the presence of alcohol misuse. 5. Cutting Down, Annoyance by Criticism, Guilty Feeling, and Eye-openers Adapted to Include Drugs (CAGE-AID): assesses the presence of substance misuse, being slightly adapted for the SMHAT (no focus on alcohol use as already explored with the AUDIT-C; additional question to explore which substance was used). 6. Brief Eating Disorder in Athletes Questionnaire (BEDA-Q): assesses the presence of disordered eating. 7. ADHD 8. Bipolar disorder 9. PTSD 10. Gambling 11. Psychosis Additionally questions to assess exercise addiction will be used as it has been shown that exercise addiction may be particularly prevalent in endurance athletes. Further questions about age, gender, country of origin, training data, past medical history and medication will be asked as well as a few specific questions about there thoughts on mental health issues as per IOC consensus paper


Recruitment information / eligibility

Status Recruiting
Enrollment 500
Est. completion date September 30, 2024
Est. primary completion date September 30, 2024
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 16 Years and older
Eligibility Inclusion Criteria: - endurance athletes (marathon runners, ultramarathon runners and triathletes) - over the age of 16 - all genders - recreational athletes (non- elite) - elite athletes (professional, international, college level) Exclusion Criteria: - athletes that that are not competing or have not competed in an official endurance race - athletes that are younger than 16 years of age.

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
mental health issues
survey on mental health issues in endurance athletes

Locations

Country Name City State
France Ultra Sports Science Foundation Pierre-Bénite

Sponsors (4)

Lead Sponsor Collaborator
Ultra Sports Science Foundation Hospital Universitario del Vinalopo, Universidade do Porto, University of South Africa

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Number of participants with mental health issues Number of participants with mental health issues March-September 2023
Secondary Number of participants with risk factors associated with mental health issues Number of participants with risk factors associated with mental health issues March-September 2023
See also
  Status Clinical Trial Phase
Active, not recruiting NCT05777044 - The Effect of Hatha Yoga on Mental Health N/A
Recruiting NCT05064293 - Assisted Identification and Navigation of Early Mental Health Symptoms in Children N/A
Not yet recruiting NCT05886595 - Being Young : My Mental Health
Active, not recruiting NCT05903638 - A Pilot RCT: the Impact of a Virtual MBSR Course on Women With Primary Infertility N/A
Not yet recruiting NCT04030858 - The INFINITE Study: A Prospective Investigation of a Nutrient-dense Diet in Early Addiction Recovery N/A
Recruiting NCT04926675 - Development of a Money Advice Intervention Within IAPT N/A
Recruiting NCT06105970 - Chinese Community Sample of Hierarchical Model of Psychopathology
Recruiting NCT06038721 - Unified Protocol: Community Connections N/A
Not yet recruiting NCT04978194 - Effects of an Intervention on University Students' Mental Health and Learning During COVID-19 N/A
Completed NCT05056428 - Effects of Mindfulness Training on Emotional Care Strategies N/A
Recruiting NCT06144905 - Norwegian Microbiota Study in Anorexia Nervosa
Completed NCT06080685 - Efficacy of Character Strengths Intervention in Enhancing Character Strengths and Self-esteem Among Adolescents N/A
Not yet recruiting NCT06266936 - Smart Life Smart Living Intercontinental - Medical Students' Cohort
Not yet recruiting NCT06187701 - Co-Active Therapeutic Theatre (Co-ATT) for Dual-Diagnosis Patients N/A
Not yet recruiting NCT06430853 - Psychobiological Interventions in Pregnancy N/A
Not yet recruiting NCT06006936 - Testing an Evidence-Based Self-Help Program for Infertility-Related Distress in Women N/A
Not yet recruiting NCT05979649 - An Internet-Based Intervention With Peer Support for the Mental Health of Youths N/A
Recruiting NCT05492305 - Glucagon-like Peptide 1 (GLP1) Receptor Agonists and Mental Health
Not yet recruiting NCT05316948 - Mental Health and Sexuality in Adolescents and Young Adults
Completed NCT05598697 - Economic Evaluation of the MEWE Intervention N/A